I suspect there are fundamental issues with the FDA process that the company is not disclosing. The management has a serious credibility issue. With the assertion that data verification has been completed and submission will be done in August yet again proven to be false (1 day left for them to prove otherwise), the management must be held to account at the upcoming AGM.
- Forums
- ASX - By Stock
- Ann: Influenza B Detection Expected to Impact on Quarter Sales
I suspect there are fundamental issues with the FDA process that...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GSS (ASX) to my watchlist
|
|||||
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $169.9M |
Open | High | Low | Value | Volume |
0.0¢ | 75.0¢ | 72.5¢ | $357.1K | 473.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 74.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
75.5¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 0.740 |
1 | 3500 | 0.720 |
1 | 700 | 0.715 |
1 | 3500 | 0.700 |
1 | 1440 | 0.695 |
Price($) | Vol. | No. |
---|---|---|
0.755 | 15000 | 1 |
0.760 | 23008 | 1 |
0.795 | 1259 | 1 |
0.800 | 15049 | 2 |
0.820 | 6408 | 2 |
Last trade - 16.12pm 09/08/2024 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
Day chart unavailable